Health Care/Hospital
RhoVac Confirms Forecast - BRaVac Phase IIb study recruitment to close in Quarter 3 2021
STOCKHOLM, May 31, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today,May 31, 2021, that it confirms its previous forecast to be able to conclude recruitment for its multi-centre BRaVac Phase IIb study in Quarter 3 2021. Also, all new US clinics hav...
2021-05-31 19:33
1596
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services
* Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 * The addition will enable Samsung Biologics to provide end-to-end mRNA vaccine manufacturing services from bulk drug substance to aseptic fill/finish ...
2021-05-31 19:00
1994
Moleac Announces US FDA Approval of IND Application for Phase 1 Study of MLC1501 Programme in Post-Traumatic Brain Injury Recovery
SINGAPORE, May 31, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, announced the approval by the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for MLC1501 in traumatic brain injury (TBI). Moleac is dedicated in finding, devel...
2021-05-31 18:33
1339
Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions
SHENZHEN, China, May 31, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the launch of its new General Imaging, Women's Healthcare, and Cardiology ultrasound solutions onMay 28, 2021. Underpinned by the theme "In...
2021-05-31 10:15
6728
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
* HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development * HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021 HOUSTON andSINGAPORE, May 31, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing pr...
2021-05-31 10:00
1704
OPAS: A Game-Changer in Post Covid-19 Landscape
PORTLAND, Ore., May 31, 2021 /PRNewswire/ -- We believe that it's safe to say that Covid-19 will likely be one of the defining events of 2021, and it will further have implications that will keep surfacing for years to come. The situation is drastically changing, and the amount of people that are...
2021-05-31 09:00
1753
An Taiwanese Hearing-impaired Actor, Easton Dong Calls Out the "Listen Love" Project, to Raise Concerns for Hearing-impaired Students during the Covid-19 Pandemic.
TAIPEI, May 31, 2021 /PRNewswire/ -- The "Listen Love" donation project, led by Easton Dong, a hearing-impaired actor inTaiwan, and co-sponsored by TaerInno, aims to bring transparent masks to hearing-impaired students. Mr. Dong advocates this campaign to bring people awareness of difficulties en...
2021-05-31 08:00
1605
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.
SEOUL, South Korea, May 30, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced onMay 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug developer, for about5.5 million U.S. dollars. As a result, Nexturn...
2021-05-30 22:00
3247
IFF 2021 Opens with Green Initiatives for a More Sustainable Future
BEIJING, May 29, 2021 /PRNewswire/ -- International Finance Forum (IFF) starts its two-day 2021 Spring Meetings today. EntitledGlobal Governance and Development in the Post-Pandemic Era, the meeting aims to provide a platform for in-depth discussions on international cooperation and global govern...
2021-05-29 20:56
3800
Second Global Health Forum of Boao Forum for Asia to be Held in Qingdao, Discussing "Health for All"
QINGDAO, China, May 28, 2021 /PRNewswire/ -- The Boao Forum for Asia (BFA) will hold the second Global Health Forum at the China Railway Qingdao World Expo City Conference Center inQingdao, China, from June 1-4, 2021. With the slogan "Health for All", the conference will convene representatives f...
2021-05-28 22:23
4156
Revolutionary X-ray Technology From Australia to Transform American Airport Security
SeaTac chosen for Micro-X Inc's USA headquarters Official Opening at 10 am PDT, Friday May 28 855 S 192nd Street, Suite B600, Seattle, WA 98148 With: * Congressman Adam Smith, chair of the House Armed Services Committee * Brigadier Hugh Meggitt representing Australian Defence Staff, Embassy o...
2021-05-28 21:00
2827
Dr. Seungpil Yu will hold a retirement ceremony and conclude his 46-year term as a pharmaceutical executive.
SEOUL, South Korea, May 28, 2021 /PRNewswire/ -- Dr. Seungpil Yu is a living witness to the long history of Yuyu Pharma, which celebrated its 80th anniversary this year, having laid the foundation for Yuyu Pharma to continue to thrive well into its 100th year. While in the United States, Dr. Yu r...
2021-05-28 21:00
2918
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management
* Expanding upon its existing ISO22301 certification, Samsung Biologics is now fully certified with Business Continuity Management System for Security and Resilience across all business areas * Samsung Biologics adds ISO50001, ISO45001, ISO14001 for Energy Management, Occupational Health and ...
2021-05-28 20:00
2518
Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management
SHANGHAI, May 28, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the launch of the patient management service focusing on the profes...
2021-05-28 18:30
4749
Year-end report, May-April 2020/21
Accelerated order growth STOCKHOLM, May 28, 2021 /PRNewswire/ -- During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order. Installation volumes were similar to levels in the fourth quarter ...
2021-05-28 14:24
12899
FRISO Launches Search for Chief Poop Officers on World Digestive Health Day
SINGAPORE, May 28, 2021 /PRNewswire/ -- FRISO today announced its nationwide search for 'Chief Poop Officers' in every household across the island as part of its efforts to advocate good digestive health and nutrient absorption in young children. Launched to coincide with World Digestive Health D...
2021-05-28 13:06
2250
Zimmer Biomet's ROSA Knee System awarded Orthopaedic Product Innovation of the Year at the recently concluded Healthcare Asia Medtech Awards 2021.
SINGAPORE, May 28, 2021 /PRNewswire/ -- Zimmer Biomet, a global leader in musculoskeletal healthcare, today announced that Zimmer Biomet's ROSA Knee was awarded the Orthopaedic Product Innovation of the Year at the recently concluded 2021 Healthcare Asia Medtech Awards. The inaugural 2021 Heal...
2021-05-28 09:00
3859
International Finance Corporation and Mitsui to invest c.US$60 million in Singapore-based MiCare Health Technologies
SINGAPORE, May 28, 2021 /PRNewswire/ -- MiCare HealthTEC Holdings Pte Ltd ("MiCare"), a subsidiary of Zuellig Pharma and a leading medical claims administrator in the region, has announced that the International Finance Corporation (IFC), a member of the World Bank Group, and Mitsui & Co. (Asia ...
2021-05-28 09:00
3188
CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application
* Sugemalimab becomes the world's first anti-PD-1/PD-L1 monoclonal antibody to successfully improve progression-free survival (PFS) in patients with stage III non-small-cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * Sugemalimab is also t...
2021-05-28 08:10
7381
AffaMed Therapeutics Announces Approval for the Phase IIb Clinical Study of AM006 in China for the Treatment of Parkinson's Disease
SHANGHAI, May 27, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, today announced thatChina's National Medical Products Administrati...
2021-05-28 08:00
1288
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
9065
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
7332
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
6976
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
6749
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
6707
